Additional Stimulation of sGC on Top of Standard Treatment With ARB`s May Offer a New Therapeutic Approach for the Treatment of Diabetic Nephropathy Resistant to ARB Treatment Alone

BMC Pharmacology
doi 10.1186/1471-2210-11-s1-p1

Related search